我国医药产业发展迅速,但是本身存在巨大安全隐患。本文将分别从创新因素、劳动力因素、环境因素、外资因素、竞争因素及政策因素等方面分别阐述我国医药产业的现状和安全隐患。并结合实际案例指出我国医药产业安全的不足。尽管我国在政策上快速地完善与医药产业相关的法规和法制,但是由于我国医药产业自身创新能力低下、资金不足、缺乏高新技术及高级管理人才,并且还面临着巨大的环保压力,这些成为制约我国医药产业发展的重要因素。
<<Although China’s pharmaceutical industry is growing rapidly,the potential safety hazard exists. This paper shows the status and potential safety hazard of China’s pharmaceutical industry in terms of innovation,labor,environment,foreign capital,competition and policy etc. The disadvantage of China’s pharmaceutical industry safety will be also displayed through combining with the real-life case. A great deal of laws and regulations related to the pharmaceutical industry safety have been made,but the development of China’s pharmaceutical industry will be restricted by factors,such as the weakness of innovation ability,the deficiency of capital,the shortage of high and new technology and senior management personel and the pressure from environmental pollution.
<<